APL2-304
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Apellis Pharmaceuticals, Inc
Start Date
November 2, 2018
End Date
November 13, 2022
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Apellis Pharmaceuticals, Inc
Start Date
November 2, 2018
End Date
November 13, 2022